Anders Nymark Christensen

Rigshospitalet, Technical University of Denmark

Papers

2

Total Citations

39

H-Index

2

About

Anders Nymark Christensen is a pioneering researcher at the intersection of surgical oncology and molecular imaging, based at the University of Copenhagen and Rigshospitalet. His work centers on developing advanced intraoperative guidance technologies—specifically, uPAR-targeted fluorescent imaging and multimodal soft tissue markers—to bridge the gap between high-resolution diagnostics and precise therapeutic intervention. In his landmark 2019 study (22 citations), Christensen demonstrated that uPAR-targeted fluorescence guidance significantly improves surgical resection of metastatic pancreatic cancer compared to traditional white-light surgery, offering a tangible path to better patient outcomes. His 2020 work (17 citations) introduced innovative “smart” soft tissue markers that translate diagnostic imaging sensitivity into real-time surgical cues, addressing a critical limitation in current practice. With a growing citation impact and a clear focus on translating bench discoveries to bedside solutions, Christensen is shaping the future of image-guided surgery—making invisible disease visible and resectable.

Research Focus

Key Achievements

2
H-Index
2
Papers
39
Total Citations
20
Avg Citations/Paper
🏆 Most Cited Paper
Improved surgical resection of metastatic pancreatic cancer using uPAR targeted <i>in vivo</i> fluorescent guidance: comparison with traditional white light surgery
22 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 29
🏛 Institutions: Rigshospitalet, Technical University of Denmark

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago